FDA-Approved Peptides: The Major Drugs (2026)
Most peptides discussed online are research compounds with no regulatory approval. But a growing number of peptide drugs have cleared the FDA's full review process and are prescribed every day. This guide covers the most notable FDA-approved peptide medicines, explains what "FDA-approved" genuinely means, and shows why that distinction matters more than almost anything else in this field.
Important. This article is educational and is not medical advice. FDA-approved peptide medicines are prescription drugs — they should only be used under the supervision of a licensed clinician. Research peptides are not approved for human use.
| Peptide | Brand(s) | Approved Use | Class |
|---|---|---|---|
| Semaglutide2017 (diabetes), 2021 (obesity) | Ozempic, Wegovy, Rybelsus | Type 2 diabetes; chronic weight management | GLP-1 receptor agonist |
| Tirzepatide2022 (diabetes), 2023 (obesity) | Mounjaro, Zepbound | Type 2 diabetes; chronic weight management | GIP/GLP-1 dual agonist |
| Liraglutide2010 (diabetes), 2014 (obesity) | Victoza, Saxenda | Type 2 diabetes; chronic weight management | GLP-1 receptor agonist |
| Tesamorelin2010 | Egrifta | HIV-associated lipodystrophy (excess abdominal fat) | GHRH analogue |
| Sermorelin1997 | Geref (historic — limited current marketing) | Growth hormone deficiency (diagnostic/therapeutic) | GHRH analogue |
| Setmelanotide2020 | Imcivree | Rare genetic obesity (POMC, LEPR, PCSK1 deficiency) | MC4R agonist |
| Bremelanotide2019 | Vyleesi | Hypoactive sexual desire disorder (premenopausal women) | Melanocortin agonist |
| GlucagonMultiple (long-established) | GlucaGen, Gvoke, Baqsimi | Severe hypoglycaemia rescue | Peptide hormone |
| Teriparatide2002 | Forteo | Osteoporosis (bone formation) | Parathyroid hormone fragment (1–34) |
| Linaclotide2012 | Linzess | IBS-C and chronic constipation | Guanylate cyclase-C agonist |
| Octreotide1988 | Sandostatin | Acromegaly; neuroendocrine tumour symptoms | Somatostatin analogue |
| Leuprolide1985 | Lupron | Prostate cancer; endometriosis; central precocious puberty | GnRH agonist |
This is a selection of the most notable and widely used FDA-approved peptide medicines, not an exhaustive list of every approved peptide — dozens of older peptide hormones and analogues are also approved. Some entries (for example sermorelin/Geref) reflect historical approvals and may have limited or no current US marketing; always verify a product's current status and labelling with a clinician or official FDA sources.
Proven safety and efficacy
An FDA-approved peptide has cleared Phase 1–3 clinical trials demonstrating, with statistical rigour, that its benefits outweigh its risks for a specific approved use (the 'indication'). This is a fundamentally different evidence bar than a research peptide, which may have only animal data or small early-stage human studies.
Manufactured to pharmaceutical standards
Approved peptides are made under cGMP (current Good Manufacturing Practice) with verified identity, purity, sterility, and consistent dosing. Research-grade peptides carry no such guarantee and are explicitly labelled 'not for human consumption.'
Prescribed for a defined indication
Approval is always for a named condition and population. A drug approved for type 2 diabetes is not automatically approved for weight loss — that requires its own trial (which is why semaglutide and tirzepatide each carry separate brand names and approvals for obesity).
Subject to ongoing oversight
Post-marketing surveillance, adverse-event reporting, and label updates continue for the life of the drug. Problems discovered after launch can trigger new warnings or withdrawal — a safety net that does not exist for grey-market research compounds.
The peptides most people have actually heard of — Ozempic, Wegovy, Mounjaro, Zepbound — are all GLP-1-based. Semaglutide mimics the gut hormone GLP-1 to slow gastric emptying, blunt appetite, and improve glycaemic control. Tirzepatide goes further, acting on both the GIP and GLP-1 receptors, and has produced the largest average weight reductions of any approved peptide to date.
Their approval pathway is instructive: each was approved first for type 2 diabetes, then required a separate large obesity trial (and a separate brand name) before it could be marketed for weight management. That is the FDA system working exactly as designed — approval is tied to a specific, tested indication, not to a molecule in the abstract. To understand the mechanism in depth, see how GLP-1 works for weight loss.
This is the single most important takeaway. Popular research peptides — BPC-157, TB-500, Epitalon, the GH secretagogues — are not FDA-approved. They are sold for laboratory research and labelled "not for human consumption." Some have promising preliminary data; none have completed the full trials required for approval, and their manufacturing is not regulated for human use.
Being unapproved does not automatically mean a peptide is unsafe or ineffective — it means the high-quality evidence and quality-control guarantees that come with approval simply do not exist yet. Several of these compounds are in active trials; we cover the most advanced of them in our companion guide on promising peptides in clinical trials.
If you are weighing research compounds, read are peptides safe? and are peptide suppliers legit? first.
Peptide Detail Profiles
Related Guides
Other Articles
Calculator
Calculate exact reconstitution volumes and insulin unit doses for any peptide protocol.
Open Calculator →